Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
European Union Recommended NAION Warnings In June 2025, the European Medicines Agency (EMA) recommended updating the labeling for semaglutide to list NAION as a very rare side effect, affecting up to 1 in 10,000 users
While it is still unclear as to what may cause a person taking a GLP-1 medication to experience an eye issue, researchers hypothesize that rapid changes in blood sugar levels might contribute to these eye complications
25 Jan 2026 | Originally published Ask, share, connect
It's a meaningful indicator that the platform has been reviewed against defined standards, though it doesn't guarantee clinical outcomes or predict future regulatory changes
US$ 29.72
US$ 28.25
US$ 29.82
US$ 22.39
US$ 24.01
US$ 29.12
US$ 20.74
